On the public citation graph

Novel Sulfonyl-Substituted Tetrandrine Derivatives for Colon Cancer Treatment by Inducing Mitochondrial Apoptosis and Inhibiting PI3K/AKT/mTOR Pathway

https://doi.org/10.2139/ssrn.4633896
0 signed · 36 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/978-1-4939-7234-0_23openalex-extracted
Targeting the PI3K/AKT/mTOR Pathway in Bladder Cancer
inferredcites →https://doi.org/10.1007/s10822-012-9584-8openalex-extracted
FRED and HYBRID docking performance on standardized datasets
inferredcites →https://doi.org/10.1016/j.biopha.2017.10.116openalex-extracted
Tetrandrine and cancer – An overview on the molecular approach
inferredcites →https://doi.org/10.1016/j.biopha.2020.111042openalex-extracted
Novel sulfonamide porphyrin TBPoS-2OH used in photodynamic therapy for malignant melanoma
inferredcites →https://doi.org/10.1016/j.cell.2017.07.029openalex-extracted
The PI3K Pathway in Human Disease
inferredcites →https://doi.org/10.1016/j.chembiol.2010.02.007openalex-extracted
A Structure-Guided Approach to Creating Covalent FGFR Inhibitors
inferredcites →https://doi.org/10.1016/j.chembiol.2011.11.010openalex-extracted
Discovery of Potent and Selective Covalent Inhibitors of JNK
inferredcites →https://doi.org/10.1016/j.ejmech.2013.09.022openalex-extracted
New synthetic aliphatic sulfonamido-quaternary ammonium salts as anticancer chemotherapeutic agents
inferredcites →https://doi.org/10.1016/j.ejmech.2017.01.008openalex-extracted
Design and synthesis of novel tetrandrine derivatives as potential anti-tumor agents against human hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.ejmech.2017.11.007openalex-extracted
Design and synthesis of novel C14-urea-tetrandrine derivatives with potent anti-cancer activity
inferredcites →https://doi.org/10.1016/j.ejmech.2020.112181openalex-extracted
Synthesis and structure-activity relationship study of water-soluble carbazole sulfonamide derivatives as new anticancer agents
inferredcites →https://doi.org/10.1016/j.ejmech.2020.112867openalex-extracted
A red-light-activated sulfonamide porphycene for highly efficient photodynamic therapy against hypoxic tumor
inferredcites →https://doi.org/10.1016/j.ejmech.2022.114739openalex-extracted
A close look into the biological and synthetic aspects of fused pyrazole derivatives
inferredcites →https://doi.org/10.1016/j.ejmech.2023.115366openalex-extracted
N(14)-substituted evodiamine derivatives as dual topoisomerase 1/tubulin-Inhibiting anti-gastrointestinal tumor agents
inferredcites →https://doi.org/10.1016/j.nut.2007.07.003openalex-extracted
α-Linolenic acid attenuates high glucose-induced apoptosis in cultured human umbilical vein endothelial cells via PI3K/Akt/eNOS pathway
inferredcites →https://doi.org/10.1016/j.phrs.2020.105377openalex-extracted
Triptolide delivery: Nanotechnology-based carrier systems to enhance efficacy and limit toxicity
inferredcites →https://doi.org/10.1016/j.phrs.2022.106415openalex-extracted
Voacamine is a novel inhibitor of EGFR exerting oncogenic activity against colorectal cancer through the mitochondrial pathway
inferredcites →https://doi.org/10.1016/j.phymed.2022.154015openalex-extracted
Activation of mitochondrial-associated apoptosis signaling pathway and inhibition of PI3K/Akt/mTOR signaling pathway by voacamine suppress breast cancer progression
inferredcites →https://doi.org/10.1016/j.semcancer.2019.12.008openalex-extracted
Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy
inferredcites →https://doi.org/10.1021/acs.jafc.1c02620openalex-extracted
Isorhamnetin Promotes MKN-45 Gastric Cancer Cell Apoptosis by Inhibiting PI3K-Mediated Adaptive Autophagy in a Hypoxic Environment
inferredcites →https://doi.org/10.1021/acs.jmedchem.6b00788openalex-extracted
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions
inferredcites →https://doi.org/10.1038/nrc2664openalex-extracted
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
inferredcites →https://doi.org/10.1038/nri1056openalex-extracted
PI3K in lymphocyte development, differentiation and activation
inferredcites →https://doi.org/10.1038/s41467-017-01565-6openalex-extracted
RETRACTED ARTICLE: A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer
inferredcites →https://doi.org/10.1038/s41573-022-00542-zopenalex-extracted
Advances in covalent drug discovery
inferredcites →https://doi.org/10.1039/c8md00125aopenalex-extracted
Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents
inferredcites →https://doi.org/10.1039/d2qo01724eopenalex-extracted
Carbene-catalyzed kinetic resolution of bispirooxindoles: selective lactam amidation and access to challenging chiral scaffolds
inferredcites →https://doi.org/10.1080/21655979.2021.1973877openalex-extracted
Quercetin alleviates chronic renal failure by targeting the PI3k/Akt pathway
inferredcites →https://doi.org/10.1111/cbdd.14202openalex-extracted
Tetrandrine inhibits migration and invasion of BGC ‐823 and MKN ‐45 cells by regulating PI3K / AKT / mTOR signaling pathway
inferredcites →https://doi.org/10.1155/2019/7517431openalex-extracted
Tetrandrine-Induced Autophagy in MDA-MB-231 Triple-Negative Breast Cancer Cell through the Inhibition of PI3K/AKT/mTOR Signaling
inferredcites →https://doi.org/10.1186/s12943-019-0954-xopenalex-extracted
Targeting PI3K in cancer: mechanisms and advances in clinical trials
inferredcites →https://doi.org/10.21203/rs.3.rs-420385/v1openalex-extracted
inferredcites →https://doi.org/10.3389/fonc.2021.737323openalex-extracted
A Novel Strategy Conjugating PD-L1 Polypeptide With Doxorubicin Alleviates Chemotherapeutic Resistance and Enhances Immune Response in Colon Cancer
inferredcites →https://doi.org/10.3389/fphar.2023.1149478openalex-extracted
Bruceine a exerts antitumor effect against colon cancer by accumulating ROS and suppressing PI3K/Akt pathway
inferredcites →https://doi.org/10.3390/cancers13081790openalex-extracted
Novel Benzenesulfonate Scaffolds with a High Anticancer Activity and G2/M Cell Cycle Arrest
inferredcites →https://doi.org/10.3390/molecules27134040openalex-extracted
Design, Synthesis, and Biological Evaluation of N14-Amino Acid-Substituted Tetrandrine Derivatives as Potential Antitumor Agents against Human Colorectal Cancer
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.